Response of Fibroblastic Rheumatism to Infliximab

Onset is usually sudden with symmetrical articular involvement of both small and large joints, occurrence of solid skin nodules, and rapid progression. Treatment is generally unrewarding. Here we report a severe and disabling case of FR responding favorably to infliximab therapy. After 32 weeks of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Romiti, Ricardo, Levy Neto, Mauricio, Menta Simonsen Nico, Marcello
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879224/
https://www.ncbi.nlm.nih.gov/pubmed/20585484
http://dx.doi.org/10.1155/2009/715729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879224/
https://www.ncbi.nlm.nih.gov/pubmed/20585484
http://dx.doi.org/10.1155/2009/715729

Ejemplares similares